Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

To main content To sitemap To news Check availability details

Travel grant 2025 Switzerland, Swiss Nordic Bio 2025 on March 13.

Reference number
Coordinator Resitu Medical AB
Funding from Vinnova SEK 0
Project duration February 2025 - March 2025
Status Completed
Venture Global cooperation 2025

Important results from the project

Yes, the goal of finding interested investors was achieved.

Expected long term effects

A lot of capital is needed when a medical technology product comes to market, so investors will be contacted continuously for several years to come.

Approach and implementation

Participation in the SwissNordicBio investor conference in Zurich.

External links

The project description has been provided by the project members themselves and the text has not been looked at by our editors.

Last updated 28 March 2025

Reference number 2025-00204